Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 15 (1) , 42-48
- https://doi.org/10.1007/bf00253598
Abstract
Radioimmunoscintigraphy (RIS) with 131I labeled OC-125 F(ab')2 monoclonal antibody fragments was prospectively studied in 43 women for primary diagnosis and follow up of ovarian cancer. Total body planar photoscans with a scintillation camera were performed one to seven days after antibody application and results were compared with operation and or CT examination. By the region of interest technique the tumor to non tumor tissue ratio (T/N) was calculated in vivo. Sensitivity in primary diagnosis was 100% (10/10), specificity 33% (1/3). For local recurrency, sensitivity was 86% (19/22), for metastatic loci 80% (17/21). Specificity was 75% and 50%. T/N ratio was in the rage from 1.3 to 2.8. Sensitivity for ovarian cancer is high in primary diagnosis and follow up. By the region of interest technique it is possible to detect small recurrencies and to presume peritoneal carcinosis. Antibody accumulations in diseases different from ovarian cancer however diminish specificity.This publication has 20 references indexed in Scilit:
- Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphataseThe British Journal of Radiology, 1986
- Serum CA 125 in Ovarian Pathology and Its Variation in Ovarian Carcinoma after Integrated TherapyGynecologic and Obstetric Investigation, 1986
- A hapten-specific chimaeric IgE antibody with human physiological effector functionNature, 1985
- Radionuclide imaging of ovarian tumours with 123I‐labelled monoclonal antibody (NDOG2) directed against placental alkaline phosphataseBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Diagnosis and treatment of neoplasms with radionuclide-labeled antibodiesSeminars in Nuclear Medicine, 1985
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.BMJ, 1981
- Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with CarcinomaNew England Journal of Medicine, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978